ADO and B-cell chronic lymphocytic leukemia: In keeping with the immunomodulatory effects registered in the T cell compartment, metabolic adaptation induced by the hypoxia-ADO axis on leukemic B cells tunes CLL cytokine production and release and favors the acquisition of a B-regulatory phenotype, as defined by a marked upregulation of IL-10 (171).